Chattem Revenue and Competitors

Claim your profile

Bridgewater, NJ USA

Location

N/A

Total Funding

Consumer

Industry

Estimated Revenue & Valuation

  • Chattem's estimated annual revenue is currently $82.6M per year.(i)
  • Chattem's estimated revenue per employee is $276,100

Employee Data

  • Chattem has 299 Employees.(i)
  • Chattem grew their employee count by -9% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.4M482%N/AN/A
#2
$4.7M33-15%N/AN/A
#3
$5120M53554%N/AN/A
#4
$6.6M3332%N/AN/A
#5
$19.8M967%N/AN/A
#6
$8.8M53-2%N/AN/A
#7
$46.1M16730%N/AN/A
#8
$21.3M1037%N/AN/A
#9
$16.5M73-8%N/AN/A
#10
$1.8M1220%N/AN/A

keywords:N/A

N/A

Total Funding

299

Number of Employees

$82.6M

Revenue (est)

-9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Chattem News

2022-04-20 - L-Ammonium Lactate Market Size 2022-2029| Key Players ...

Chattem Chemicals; SHXSHW; Jindan; Musashino Chemical. L-Ammonium Lactate Market Breakdown by Type: General Grade; Cosmetic Grade.

2022-04-20 - Disinfection and Hand Sanitizer Market Size 2022-2030| Key ...

Reckitt Benckiser; Chattem (Sanofi); P&G; Amway; 3M; Unilever; Shanghai Jahwa Corporation; Lion Corporation; Henkel; Medline; GOJO Industries; Bluemoon...

2022-04-19 - Foot Care Medicated Creams Market Size, Outlook And ...

GEHWOL, Chattem, Flexitol, Kerasal, Nixsi Ltd., Pro Clearz Fungi-Cide (HUMAN OTC DRUG LABEL), Lamisil, Litromin, Tinactin (Bayer HealthCare), PediFix Inc.,...

2009-01-13 - BiPar snags $20M for inhibitor-based cancer therapies

Pharmaceutical firm BiPar Sciences just brought in $20 million in private equity and venture debt to advance its lead therapy, targeting breast cancer, to phase-three clinical trials. The investment will double the Brisbane, Calif.-based company’s cash on hand, a huge vote of confidence for its ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$58.5M32320%N/A
#2
$141M38919%N/A
#3
$63.1M535N/AN/A
#4
$165.4M538-10%N/A
#5
$145.2M553N/AN/A